Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pterin-4-alpha-carbinolamine dehydratase 2 (PCBD2) is an enzyme involved in tetrahydrobiopterin biosynthesis. It also functions as a dimerization cofactor for hepatocyte nuclear factor 1 alpha (HNF-1-alpha), enhancing transcriptional activity. PCBD2 is implicated in several diseases, including cancer and genetic disorders like Noonan Syndrome 9 and hyperphenylalaninemia. It is primarily located in the mitochondria but can shuttle between cytoplasm and nucleus to exert its effects. PCBD2 is not a conventional ion channel but may serve as a regulatory or scaffolding element in various cellular processes[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pterin-4-alpha-carbinolamine dehydratase 2 (PCBD2).